19 February 2024
LEI: 213800RG7JNX7K8F7525
Life Science REIT
plc
("Life Science REIT"
or the "Company")
Notice of Full Year
Results
Life Science REIT (LSE: LABS), the real estate
investment trust focused on UK life science properties, is pleased
to announce that it will report its results for the year ended 31
December 2023 on Tuesday, 26 March 2024.
A meeting for analysts
will be held at 10.30am on the morning of 26 March at the
offices of Buchanan, 107 Cheapside, London EC2V
6DN. The presentation will be hosted by Ironstone
Asset Management, the Company's Investment Adviser.
Analysts who wish to attend the meeting, please
RSVP to lifesciencereit@buchanan.uk.com
Following the meeting, a recording of the
audiocast will be made available for replay at the Company's
website, https://lifesciencereit.co.uk
Enquiries:
|
Ironstone Asset Management - Investment
Adviser
|
+44 20 3011 2160
|
|
Simon Farnsworth, Managing
Director
Simon.farnsworth@ironstoneam.com
|
|
|
Joanna Waddingham, Head of Investor
Relations and Corporate Affairs
|
|
|
Joanna.Waddingham@ironstoneam.com
|
|
|
|
|
|
Link Company Matters Limited - Company
Secretary
|
|
|
labs_cosec@linkgroup.co.uk
|
|
|
|
|
|
Panmure Gordon (UK) Limited - Joint Corporate
Broker
|
+44 20 7886 2500
|
|
Alex Collins / Tom
Scrivens
|
|
|
|
|
|
Jefferies International Limited - Joint Corporate
Broker
|
+44 20 7029 8000
|
|
Tom Yeadon / Oliver
Nott
|
|
|
G10
Capital Limited - AIFM
|
+44 20 7397 5450
|
|
Maria Baldwin
|
|
|
Buchanan - Financial PR
|
+44 20 7466 5000
|
|
Mark Court / Henry Wilson / Verity
Parker
|
|
|
LifeSciencereit@buchanan.uk.com
|
|
Notes to editors
Life Science REIT plc is a
specialist property business focused on the UK's growing life
science sector. The Company's portfolio of assets is located across
the "Golden Triangle" of research and development hubs in Oxford,
Cambridge and London's Knowledge Quarter and its strategic vision
is to become the property provider of choice for life science
companies in the UK.
Life Science REIT is addressing the
acute demand-supply imbalance for laboratory space in the "Golden
Triangle", which is characterised by low vacancy rates and prime
rental increases. The UK life science sector itself is benefiting
from a buoyant early-stage funding environment, driving demand for
laboratory space.
The Company's diverse portfolio of
assets ranges from a 20-acre science park currently under
development through to fully let buildings, with an important part
of the Company's strategy being the conversion of existing
properties to laboratory space.
The Company's investment policy is
focused on capital growth whilst also providing a growing level of
income.
Life Science REIT trades on the Main
Market of the London Stock Exchange under the ticker
LABS.
Further information is available
at https://lifesciencereit.co.uk.
To sign up for email alerts, please visit https://lifesciencereit.co.uk/investors/.